Explore the Agenda
8:00 am Registration & Coffee
8:50 am Chair’s Opening Remarks
Aligning Employer & Payer Strategies to Strengthen Sustainable Coverage
9:00 am Reimagining Federal Policy Solutions for Employer Coverage of High- Cost Advanced Therapies
- Understanding how employer funded plans approach coverage, financial risk and policy decisions for high-cost cell and gene therapies
- Identifying federal policy options that could help stabilize employer risk exposure, including new payment models, reinsurance approaches, and regulatory pathways for value-based arrangements
- Exploring how federal policy can enable sustainable coverage of advanced therapies while protecting employer plan affordability and patient access
9:30 am Navigating Coverage Decisions for Cell & Gene Therapies: A Payer Perspective
- Balancing clinical evidence standards, financial risk and member access
- Supporting employer evaluation of high-cost therapies, including the use of carveouts, reinsurance, and care management strategies.
- Assessing differences between large and small employer groups and their sensitivity to single high-cost claims
10:00 am Morning Break & Networking
Strengthening Access Readiness for Upcoming Launches Across Indications Beyond Oncology & Rare Disease
11:00 am Navigating Access & Policy Barriers for the Next Generation of Cell & Gene Therapies
- Addressing access obstacles and new considerations in emerging indications to expand CAR‑T cell therapy and gene therapy delivery beyond oncology and smaller indications
- Policy challenges and opportunities to broaden treatment reach across the US outside major academic centres and improving patient access pathways
- Identifying key areas of reimbursement and access policy shaping that will enable future patients to receive innovative therapies
11:45 am Evolving Access Pathways for Cell & Gene Therapies in Parkinson’s Disease
- Opportunities and challenges in coding, coverage, reimbursement, and policy for cell and gene therapies in a common neurodegenerative disease
- Lessons from existing payment models and priorities to enable sustainable access in the future
12:15 pm Lunch Break & Networking
Applying Real‑World Launch Insights to Improve Coverage Pathways & Patient Adoption
1:15 pm Building Payer Confidence from Prelaunch to Year One
- Defining the economic case early to align pricing with payer value expectations
- Supporting diverse practice settings with financial pathways that reduce provider risk
- Using innovative ideas for first year payment support to accelerate early Medicare claims and speed up provider confidence
1:45 pm Case Study: Advancing Patient Access Through Early Engagement with Payers & the Cell & Gene Therapy Access Model
- Engaging payers early to educate on the product and disease state while generating appropriate outcomes to support contracting
- Building evidence of value to drive coverage while addressing reimbursement challenges for qualified treatment centres
- Showcasing substantial growth in patient adoption over two years, and outlining challenges that remain
2:15 pm Afternoon Break & Networking
Navigating Credentialing & Payment Complexity to Support Sustainable Cell & Gene Therapy Access
3:00 pm Streamlining Out-of-State Medicaid Provider Credentialing to Accelerate Cell & Gene Therapy Access
- Highlighting how fragmented state credentialing rules create delays for patients receiving care out-of-state
- Outlining practical, scalable recommendations to streamline Medicaid provider credentialing for children and adults who need timely access to specialist‑delivered therapies
- Next steps for implementing the Accelerating Kids Access to Care Act, recently passed by Congress
3:30 pm Advancing Sustainable Payment Strategies for Cell & Gene Therapies
- Creating flexible payment structures that reduce upfront burden and support broader patient access
- Applying payment approaches to align reimbursement with outcomes and essential procedural steps
- Leveraging Medicaid to carve out policies to secure additional rebates and maintain access in financially constrained environments